Herpes Simplex Virus-1 gD Recombinant
Herpes Simplex Virus-1 gD (84-175 a.a.) Recombinant
The E.Coli derived recombinant protein contains the HSV-1 gD (84-175) immunodominant region.
Herpes Simplex Virus-1 gG Recombinant
Herpes Simplex Virus-2 gB Recombinant
Herpes Simplex Virus-2 gG
Herpes Simplex Virus-2 gD Recombinant
Herpes Simplex Virus-2 gD (31-335 a.a.) Recombinant
E.Coli derived HSV-2 gD recombinant protein, amino acids 31-335.
Herpes Simplex Virus-2 gD (525-578 a.a.) Recombinant
The E.Coli derived recombinant protein contains the HSV-2 gD (525-578) immunodominant region.
HSV2 gD is fused to a six histidine his tag at c-terminus and purified by proprietary chromatographic techniques.
Herpes Simplex Virus-2 gG Recombinant
Herpes Simplex Virus-2 VP13/14 Recombinant
Herpes simplex virus (HSV), commonly known as herpes, is a viral infection caused by the herpes simplex virus. There are two main types of herpes simplex virus: HSV-1 and HSV-2. HSV-1 primarily causes oral herpes, which manifests as cold sores around the mouth, while HSV-2 primarily causes genital herpes . Both types can cause infections in other areas of the body as well.
The primary biological functions of HSV include:
HSV interacts with host cells through several mechanisms:
The regulatory mechanisms that control HSV expression and activity include:
HSV has several applications in biomedical research and therapeutic strategies:
HSV plays a significant role throughout its life cycle:
Herpes simplex virus remains a significant public health concern due to its widespread prevalence and ability to cause recurrent infections. Ongoing research aims to develop effective vaccines and therapeutic strategies to better manage and prevent HSV infections.